Atom Grants
Discover

    Pfizer Independent Medical Education Grant Request for Proposals: Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology Practice

    Pfizer funds educational projects to improve community healthcare providers’ knowledge and skills in treating relapsed/refractory large B-cell lymphoma, emphasizing current therapies, management strategies, and drug resistance.

    Overview
    Eligibility
    Sources (1)
    Similar Grants
    Researchers

    Funder: Pfizer Inc.

    Due Dates: June 11, 2026 (Submission deadline for full application)

    Funding Amounts: Up to $250,000 per project; total estimated budget $500,000; max project duration 18 months.

    Summary: Supports independent medical education initiatives to improve community healthcare professionals’ knowledge and competence in managing relapsed/refractory large B-cell lymphoma.

    Key Information: Only organizations (not individuals) may apply; projects must be educational, not clinical research.


    Description

    This grant opportunity invites eligible organizations to propose independent medical education initiatives aimed at addressing knowledge and competence gaps among community healthcare professionals managing patients with relapsed/refractory large B-cell lymphoma (R/R LBCL). Supported projects should focus on improving understanding of current and emerging treatment options, therapy management strategies to minimize toxicity and optimize outcomes, and mechanisms of drug resistance or loss of response to new therapies. The program emphasizes educational formats such as workshops, digital content, conference sessions, grand rounds, online resources, and other innovative approaches to enhance the skills and knowledge of providers in community practice settings.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.